Dr. Legrand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-9035
Education & Training
University of Paris VII Faculty of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2019 - 2026
Clinical Trials
- Cardiovascular Biomarkers and Lung Edema in Severe Burns Patients Start of enrollment: 2017 Aug 06
Roles: Contact
- Timing of Surgery And Outcome in Burn Patients ( EARLYBURN ) Start of enrollment: 2016 Dec 25
Roles: Principal Investigator, Contact
- Impact of Renin-Angiotensin System Inhibitors Continuation on Outcome After Major Surgery Start of enrollment: 2018 Feb 06
Roles: Contact
Publications & Presentations
PubMed
- How to manage sodium-glucose cotransporter-2 inhibitors in the critically ill patient?Bruno Garcia, Marlies Ostermann, Matthieu Legrand
Intensive Care Medicine. 2024-12-02 - Adjusting risk of acute kidney injury for time on controlled mechanical ventilation in acute respiratory distress syndrome: victim or partner in crime? Authors' reply.Edoardo Antonucci, David Chen, Matthieu Legrand
Intensive Care Medicine. 2024-12-01 - The renin-angiotensin-aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II.Matthieu Legrand, Ashish K Khanna, Marlies Ostermann, Yuki Kotani, Ricard Ferrer
Critical Care. 2024-11-26
Press Mentions
Studies Unravel 3 Common Medical PracticesSeptember 16th, 2024- Three Medical Practices That Older Patients Should QuestionSeptember 14th, 2024
- Pause or Keep RAS Inhibitors Before Surgery? Take Your PickAugust 31st, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
